Document is current
Any future updates will be listed below
-
Authors
Waswa, J.P. https://orcid.org/0000-0001-9612-1840
Kiggundu, Reuben
Kasujja, Hassan
Vudriko, Patrick
Sendagire, Hakim
Kajumbula, Henry
Sekamatte, Musa
Kakooza, Francis
Alombah, Fozo
Joshi, Mohan P. https://orcid.org/0000-0003-4846-6312
Konduri, Niranjan https://orcid.org/0000-0002-6828-1182
-
Funding
Funding for this research was provided by:
United States Agency for International Development (7200AA18C00074)
- License Information
-
More Information
Article History
Received: 1 March 2024
Revised: 27 June 2024
Accepted: 16 July 2024
First Online: 28 August 2024
Declarations
:
: The Uganda Government granted permission to the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) program for long-term technical assistance in multisectoral coordination of antimicrobial resistance, infection prevention and control and antimicrobial stewardship. In line with Uganda’s National Action Plan on Antimicrobial Resistance, this includes permission for the review of the plan to establish implementation status, identify barriers to implementation, and make actionable recommendations. This study is part of the USAID MTaPS program’s routine technical assistance to inform priorities for AMR containment. The officials in various ministries, departments and agencies, and facilities and sites provided their respective approval and clearance. There was no direct patient contact, and all the data were anonymized when appropriate.
: The authors declare that they have no competing interests.
